FDA Orders Safety Study, Boxed Warning for Essure Permanent Contraceptive Device

In response to a surge of consumer complaints about the Essure permanent contraceptive device since October 2013, the FDA has now ordered its manufacturer, Bayer Healthcare Pharmaceuticals, to perform a postmarket safety study. In addition, the FDA has proposed a box warning and a patient checklist highlighting the potential adverse events that could occur following implantation of…